CYR61/CCN1 can inhibit the activation of the EGFR signaling pathway and the proliferation of HCC cells by interacting with the α1β1 integrins, suppressing the expression of ITGB1 and stimulating the accumulation of intracellular ROS [110, 111]. The gene discussed is ITGB1; the disease is hepatocellular carcinoma.